Read More Analyst Ratings News Price Target Credit Suisse Maintains Outperform on Intapp, Raises Price Target to $40 By Benzinga Newsdesk February 7, 8:23 AM Credit Suisse analyst Kevin Mcveigh maintains Intapp (NASDAQ:INTA) with a Outperform and raises the price target from $33 to $40. INTA
Read More Analyst Ratings News Price Target UBS Maintains Buy on FedEx, Raises Price Target to $312 By Benzinga Newsdesk June 24, 8:31 AM UBS analyst Thomas Wadewitz maintains FedEx (NYSE:FDX) with a Buy and raises the price target from $300 to $312. FDX
Read More News MoonLake Immunotherapeutics Signs Development And Manufacturing Agreement With Vetter Pharma International GmbH By Benzinga Newsdesk July 26, 8:08 AM MoonLake Immunotherapeutics AG ((MoonLake, NASDAQ:MLTX), a clinical-stage biotechnology company focused on creating next-level therapies for inflammatory diseases, today announced that it has signed a Master Development MLTX
Read More Earnings Guidance News Illinois Tool Works Q2 Result Beats Estimates, Cuts FY21 Operating Margin Outlook By Akanksha July 30, 1:43 PM Illinois Tool Works Inc. (NYSE:ITW) reported second-quarter operating revenue growth of 43% year-over-year to $3.68 billion (up 37% on an organic… ITW